• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of August 15, 2012

  • Print
  • Share
  • E-mail

Product Detail

Product Description Copaxone (glatiramer acetate injection), 20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30
Recall Number D-1442-2012
Classification Class II
Code Info Lot number X05011, Exp 08/13
Product Distributed Qty 6,647 cartons
Reason For Recall Presence of Foreign Substance: Recall is being initiated due to the presence of a foreign particle identified from a customer complaint.

Event Detail

Event Id 62241
Product Type Drugs
Status Ongoing
Recalling Firm Teva Pharmaceuticals USA, Inc.
City Sellersville
State PA
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2012-05-18
Initial Firm Notification of Consignee or Public Letter
Distribution Pattern Nationwide